Teacher Retirement System of Texas cut its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 16.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 53,671 shares of the company's stock after selling 10,865 shares during the period. Teacher Retirement System of Texas owned 0.36% of U.S. Physical Therapy worth $4,761,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the business. Copeland Capital Management LLC lifted its position in U.S. Physical Therapy by 9.5% during the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after purchasing an additional 72,715 shares in the last quarter. State Street Corp grew its stake in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock valued at $56,522,000 after acquiring an additional 99,244 shares during the period. Southernsun Asset Management LLC lifted its holdings in U.S. Physical Therapy by 10.5% during the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company's stock valued at $46,302,000 after purchasing an additional 52,062 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of U.S. Physical Therapy by 1.3% in the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company's stock worth $29,040,000 after purchasing an additional 4,477 shares in the last quarter. Finally, Bahl & Gaynor Inc. lifted its stake in shares of U.S. Physical Therapy by 135.4% during the 4th quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company's stock valued at $23,076,000 after buying an additional 149,622 shares in the last quarter.
Insider Buying and Selling
In related news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now owns 7,168 shares of the company's stock, valued at $588,564.48. This trade represents a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.70% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on USPH shares. Barrington Research dropped their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. StockNews.com cut shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Friday, February 28th. JPMorgan Chase & Co. decreased their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Wednesday, March 19th. Finally, Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. One analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $109.00.
View Our Latest Report on USPH
U.S. Physical Therapy Trading Down 0.3 %
Shares of USPH stock traded down $0.25 on Tuesday, reaching $73.41. 40,566 shares of the company's stock were exchanged, compared to its average volume of 99,745. The company's fifty day simple moving average is $84.54 and its 200 day simple moving average is $86.91. The stock has a market capitalization of $1.12 billion, a PE ratio of 78.24, a P/E/G ratio of 3.54 and a beta of 1.51. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 52 week low of $72.27 and a 52 week high of $113.63.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $180.45 million for the quarter, compared to analysts' expectations of $173.10 million. As a group, analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.
U.S. Physical Therapy Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.45%. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy's payout ratio is presently 97.83%.
U.S. Physical Therapy Profile
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.